Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study.
Saved in:
| Title: | Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study. |
|---|---|
| Authors: | Burge DJ; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Eisenman J; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Byrnes-Blake K; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Smolak P; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Lau K; 1 Resolve Therapeutics, LLC, Seattle, WA, USA., Cohen SB; 2 Metroplex Clinical Research Center, Dallas, TX, USA., Kivitz AJ; 3 Altoona Center for Clinical Research, Duncansville, PA, USA., Levin R; 4 Clinical Research of West Florida, Clearwater, FL, USA., Martin RW; 5 Michigan State University, East Lansing, MI, USA., Sherrer Y; 6 Center for Rheumatology, Immunology, and Arthritis, Ft. Lauderdale, FL, USA., Posada JA; 1 Resolve Therapeutics, LLC, Seattle, WA, USA. |
| Source: | Lupus [Lupus] 2017 Jul; Vol. 26 (8), pp. 825-834. Date of Electronic Publication: 2016 Nov 16. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9204265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-0962 (Electronic) Linking ISSN: 09612033 NLM ISO Abbreviation: Lupus Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-0962 |
|---|---|
| DOI: | 10.1177/0961203316678675 |
